The advancements being made in regenerative medicine and adult stem cell research are a reason for the global health care community to be extremely excited.
Montclair, NJ (PRWEB) April 10, 2013
CellHealth™ Institute announced today that Dr. Vincent Giampapa has accepted an invitation to present his latest preliminary research in adult stem cell reprogramming at The Second International Vatican Stem Cell Conference: Regenerative Medicine – A Fundamental Shift in Science and Culture, from within The Vatican, April 11-13, 2013.
The invitation came directly from the Vatican’s Pontifical Council for Culture, NeoStem, The Stem for Life Foundation and STOQ International as these organizations continue to promote their charter of raising global awareness on adult stem cell usage.
Dr. Vincent Giampapa will present during the third day, moderated by Dr. Max Gomez from WCBS-TV. Dr. Giampapa is a board-certified anti-aging physician and author of the first and only medical textbook on anti-aging medicine for medical doctors. He will present his research on reprogramming the function of older human stem cells at the University of Medicine and Dentistry New Jersey (UMDNJ).
“The advancements being made in regenerative medicine and adult stem cell research are a reason for the global health care community to be extremely excited,” said Dr. Vincent Giampapa, chief medical officer of CellHealth Institute. “New ideas on how we age at the cellular level, particularly stem cells, are changing our approach to the aging process in general. The opportunity provided by The Vatican’s Pontifical Council for Culture, NeoStem, The Stem for Life Foundation and STOQ International is a wonderful global platform for this discussion, and I am personally honored to play a part.”
For more information, visit CellHealth.net.
About CellHealth™ Institute
CellHealth Institute (CHI) is a biotechnology company focused on cellular health that integrates breakthrough products and services with holistic lifestyle education. CHI collaborates with top-tier research universities and publicly traded biotech companies to offer fully integrated personalized health programs paired with scientific biomarker evaluations, as well as medical-grade supplements, including everycell™, and advanced treatment through stem cell therapies. The organization is headquartered in New Jersey with an international regenerative medicine destination in Costa Rica set to open in 2014. CHI services and products allow people to take control of their own health at the most basic level – their cells.